Home ⟩ Insights

Insights

contracts

4 min read • October 23, 2024

EXCLUSIVE: Tilray CEO Irwin Simon On Why US Cannabis Rescheduling Won’t Change A Billion-Dollar Play

2 min read • October 23, 2024

Chicago Atlantic Secures BBB+ Rating And $50M Loan To Enhance Liquidity In Cannabis Lending

5 min read • October 18, 2024

Sold Out Before Hitting Shelves: Why Did AYR Wellness Snatch Up This Local Cannabis Brand?

4 min read • October 14, 2024

How Germany’s Cannabis Market Is Dominating Europe And Unlocking New Profit Opportunities

4 min read • October 14, 2024

EXCLUSIVE: How To Raise Capital In Cannabis – A Guide To Debt And Equity For Avoiding Pitfalls That Sink Most Startups

2 min read • October 11, 2024

Global Cannabis Consumer Packaged Goods SLANG At Risk: $17.3M Debt And Revenue Drops Spell Trouble

2 min read • October 11, 2024

Grown Rogue Secures $800K, Vireo Forfeits 4.5M Warrants In Cannabis Shakeup—What’s Next For Both?

2 min read • October 10, 2024

Major Cannabis Merger Approved In New York: Can Weed Stock Investors Take Advantage?

2 min read • September 18, 2024

Irish Cannabis Patients Will Now Gain Access To New Products Through This International Agreement

4 min read • September 12, 2024

New Laws Could Unleash $1.7B Demand For Cannabis Loans, This Real Estate Stock Is Set To Capitalize

4 min read • August 9, 2024

AI Technology Once Used In Cancer Research Now Develops ‘Plant Vaccines’ For Cannabis Viroids

3 min read • August 6, 2024

Vireo Growth Inc. Turns $1M Loss Into $5.8M Gain In Q2: What Investors Need To Know About This Cannabis Stock

Latest Headlines

4 min read • August 31, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

5 min read • August 31, 2026

Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell

6 min read • August 31, 2026

USCR Urges Congress to Keep the Hemp Loophole Closed

4 min read • August 28, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1

3 min read • August 28, 2026

$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says

2 min read • August 28, 2026

PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off

5 min read • August 27, 2026

Massachusetts Could Kill Its $1.6 Billion Cannabis Market and Close 300+ Stores, CEO Warns

2 min read • August 27, 2026

IM Cannabis Implements 30-for-1 Reverse Stock Split as It Fights to Maintain Nasdaq Listing

4 min read • August 26, 2026

Four Things Nobody Told You About the DEA Cannabis Hearings — But You Probably Wanted to Ask

3 min read • August 26, 2026

Financial Times: Germany’s Cannabis Imports Surge Sixfold, Regulatory Pressure Mounts

3 min read • August 25, 2026

Comply With What? Hemp Ban Nears; the FDA Leaves Industry Waiting for Answers

4 min read • August 25, 2026

Curaleaf vs. Aurora: The $4 Cannabis Takeover Fight Gets Hostile — Literally

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.